Lijun Zhang

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 3

Top Topics

End Stage Renal Disease

Prognostic Factors

Patient Reported Outcomes

Top Venues

Fundamental & clinical pharmacology

Shanghai Public Health Clinical Center

Hunan Normal University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Shanghai Public Health Clinical Center Jul 01 2006

China

PI :: Scientific research center

Education History

Hunan Normal University Sep 01 2001 - Jun 30 2006

China

PHD :: Biochemistry and molocular biology

Central South University Sep 01 1991 - Jul 01 1995

China

BSC :: Analytical chemistry

Publications

Liyan Zeng, Rui Chen, Xuhua Jiang, Feng Li, Zhaoqin Zhu, Zheng Jiao, Yun Ling, Lijun Zhang
Population pharmacokinetics and pharmacodynamics of nirmatrelvir in Chinese patients with COVID-19. Fundamental & clinical pharmacology 38 (4) (2024)
Liyan Zeng, Rui Chen, Xuhua Jiang, Feng Li, Zhaoqin Zhu, Zheng Jiao, Yun Ling, Lijun Zhang
Population pharmacokinetics and pharmacodynamics of nirmatrelvir in Chinese patients with COVID-19. Fundamental & clinical pharmacology (2024)
Zhimi Tan, Xiaofang Jia, Fang Ma, Yanling Feng, Hongzhou Lu, Jun-O Jin, Dage Wu, Lin Yin, Li Liu, Lijun Zhang
Increased MMAB level in mitochondria as a novel biomarker of hepatotoxicity induced by Efavirenz. PloS one 12 (11) (2017)